This note examines the EU's efforts to regulate gene therapy, considering the Union's resolve to establish scientifically, economically, and morally sound parameters acceptable to its varied constituency. This includes discussion of legal and ethical considerations, biotechnology goals in the EU, and EU-wide uniform regulations.
Charles F. De Jager,
The Development of Regulatory Standards for Gene Therapy in the European Union,
18 Fordham Int'l L.J. 1303
Available at: http://ir.lawnet.fordham.edu/ilj/vol18/iss4/10